This economic evaluation study estimates the economic burden of late-stage age-related macular degeneration in 3 countries.
| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | Risk of Falls and Fractures in Individuals With Cataract, Age-Related Macular Degeneration, or Glaucoma | 0 | 8.31 | 01-02-2024 |
| 2 | Machine Learning Models for Predicting Long-Term Visual Acuity in Highly Myopic Eyes | 0 | 9.79 | 01-12-2023 |
| 3 | Efficacy and Safety of Brolucizumab for Diabetic Macular Edema | 0 | 7.97 | 01-12-2023 |
| 4 | Diabetic Retinopathy and Quality of Life | 0 | 8.72 | 01-03-2024 |
| 5 | Sterile Intraocular Inflammation Associated With Faricimab | 0 | 9.17 | 01-11-2024 |
| 6 | Risk of Stroke, Myocardial Infarction, and Death After Retinal Artery Occlusion | 0 | 11.23 | 01-12-2023 |
| 7 | Interventions for Dry Eye | 0 | 6.52 | 01-01-2024 |
| 8 | Daily Low-Level Red Light for Spherical Equivalent Error and Axial Length in Children With Myopia | 0 | 13.66 | 01-06-2024 |
| 9 | Cognitive Outcomes After Catheter Ablation for Atrial Fibrillation | 0 | 8.06 | 31-07-2026 |
| 10 | Экономия | 0 | 0 | 20-07-2026 |